Literature DB >> 9884279

Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.

H Shirwan1, L Barwari, N S Khan.   

Abstract

BACKGROUND: We have recently demonstrated that three synthetic peptides corresponding to the alpha-helices of the alpha1 and alpha2 domains of the donor class I RT1.Aa molecule served as efficient CD4+ T-cell epitopes for indirect recognition of this molecule during cardiac allograft rejection in the PVG.R8-toPVG.1U rat strain combination. These peptides induce long-term graft survival when injected into the thymus 7 days before transplantation under the cover of transient immunosuppression with anti-rat lymphocyte serum. In this study, we analyzed intragraft cytokine gene expression to test whether immune deviation to the T helper (Th) 2 response is associated with long-term allograft survival in this model.
METHODS: Intragraft cytokine gene expression was analyzed using a competitive reverse transcription polymerase chain reaction method we developed for this study. Cytokine gene expression was quantified in control allografts (n=5) with acute rejection and allografts from intrathymically manipulated recipients with acute rejection (n=5), delayed rejection (n=7), or no rejection (n=8).
RESULTS: Long-surviving allografts expressed high levels of interleukin (IL)-4, IL-10, transforming growth factor (TGF)-beta, interferon (IFN)-gamma, and undetectable levels of IL-2. Allografts that were rejected in a delayed fashion expressed mostly IL-2, IFN-gamma, and TGF-beta with low or undetectable levels of IL-4 and IL-10. Acutely rejected allografts from unmanipulated controls or peptide-manipulated recipients expressed high levels of IL-2, IFN-gamma, TGF-beta and undetectable levels of IL-4 or IL-10. All allografts also expressed T-cell receptor Cbeta gene, providing evidence for the presence of T-cell infiltrates in the grafts.
CONCLUSIONS: These observations demonstrate that acute graft rejection in this model is associated with the expression of Th1 cytokines, IL-2, and IFN-gamma, whereas long-term survival is associated with predominant expression of Th2 cytokines, IL-4, and IL-10. The expression of IFN-gamma in long-surviving allografts in the absence of IL-2 provides evidence for altered activation of the Th1 response in this intrathymic immune modulation model.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884279     DOI: 10.1097/00007890-199812270-00039

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Expression of cytokines in acute heart transplantation rejection.

Authors:  Jiahong Xia; Lei Xu; Chenyuan Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 2.  Mechanism of cellular rejection in transplantation.

Authors:  Elizabeth Ingulli
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

3.  Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides.

Authors:  Ming-Qing Xu; Yu-Ping Suo; Jian-Ping Gong; Ming-Man Zhang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

4.  Class I MHC allochimeric presentation of composite immunogenic and self epitopes induces tolerance to genetically diverse rat strains.

Authors:  Natalya V Semiletova; Xiu-Da Shen; Daniel M Feldman; Feng Gao; Ana Mhoyan; Dhai Liu; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Rafik M Ghobrial
Journal:  Cell Immunol       Date:  2007-10-23       Impact factor: 4.868

5.  Understanding Streptococcus suis serotype 2 infection in pigs through a transcriptional approach.

Authors:  Manli Liu; Liurong Fang; Chen Tan; Tiansi Long; Huanchun Chen; Shaobo Xiao
Journal:  BMC Genomics       Date:  2011-05-20       Impact factor: 3.969

Review 6.  Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets.

Authors:  Adnan Bashir Bhatti; Muhammad Usman
Journal:  Cureus       Date:  2015-11-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.